– USA, CA – Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies, today announced the appointment of Dr. Tom Dietz (Ph.D.) to its board of directors, bringing nearly three decades of experience in the investment banking and pharmaceutical industries to the Board.
“Dr. Dietz will be a welcome addition to our board,” said CEO, Dr. Igor Khandros. “His guidance and extensive experience in the financial markets and numerous pharmaceutical companies will be an asset to Nutcracker Therapeutics as we continue our course towards the company’s first clinical trial.”
About Dr. Thomas J. Dietz
Dr. Diez is currently the Chairman and CEO of Waypoint Holdings, a financial holdings and services firm. Additionally, he serves as Chairman of the Board for Eiger BioPharmaceuticals, as well as a board member of Paratek Pharmaceuticals, Leap Therapeutics, and several other private companies.
Dr. Dietz began his career as a member of the research faculty at the University of California, San Francisco’s Department of Medicine. He then moved to the investment banking firm Pacific Growth Equities, where he served in various roles prior to becoming its co-CEO. The firm was eventually acquired by Wedbush Securities, from which point he served as the head of its investment banking division.
About Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA platform that encompasses the design, delivery, and manufacturing of RNA medicines. Armed with this high-tech advantage, the company has initiated multiple therapeutic programs with the support of clinical investigators at leading institutions. Nutcracker Therapeutics’ technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in speed and capacity scaling over other RNA manufacturing approaches.
For more information: https://www.nutcrackerx.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
